Tech Company Financing Transactions
AngioScore Funding Round
AngioScore, operating out of Fremont, secured $30 million in funding from Telegraph Hill Partners, JGV and Pelion Venture Partners.
Transaction Overview
Company Name
Announced On
4/11/2006
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series D
Investors
Telegraph Hill Partners (Lead Investor) (Thomas Raffin)
QuestMark Partners (Benjamin Schapiro)
Proceeds Purpose
We expect the funds from this financing will be used primarily to expand the company's global manufacturing effort and launch the AngioSculpt in the U.S. market.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
5055 Brandin Ct.
Fremont, CA 94538
USA
Fremont, CA 94538
USA
Phone
Website
Email Address
Overview
AngioScore, Inc. develops, makes and sells leading edge tools for endovascular therapy. Our first product, the AngioSculpt Scoring Balloon Catheter, has received CE mark approval and is available for sale in Europe. Clinical trials are underway in the United States.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thomas Trotter
Chief Financial Officer
James Andrews
Chief Medical Officer
Gary Gershony
VP - Operations
Samuel Omaleki
VP - Regulatory Affairs
Kent Jones
VP - Sales
Richard Cassidy
Browse more venture capital transactions:
Prev: 4/11/2006: SkinMedica venture capital transaction
Next: 4/11/2006: GreenFuel Technologies venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on tech company VC transactions. VC investment data records on this site are derived from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs